An estimated 20 million to 30 million American men have erectile dysfunction (ED). The past
2 decades of research defining erectile physiology and investigating the pathogenesis of ED …

Major advances in science and medicine have led to improved understanding of the
pathophysiology of erectile dysfunction. The development of reliable pharmacological …

Erectile dysfunction is a common condition in aging men and significantly affects their quality
of life and interpersonal relationships. Its prevalence and incidence are associated with …

Prior to the 1970s, erectile dysfunction commanded little clinical interest. Physicians rarely
questioned patients about sexual function, and patients rarely discussed sexual concerns …

Erectile dysfunction (ED) is an increasingly common problem, affecting up to 30 million
American men. This largely results from increased risk factors and an aging population. ED …

After a focused evaluation of the patient with erectile dysfunction (ED), therapy can usually
be recommended based on severity of ED and patient/partner preference. Management of …

It is widely accepted that disorders of the male (uro) genital tract, such as erectile dysfunction
(ED) and benign diseases of the prostate (lower urinary tract symptomatology or benign …

With the introduction of effective pharmacologic therapies for erectile dysfunction, more men
are seeking treatment. The underlying cause of erectile dysfunction is usually a chronic …

There is growing evidence that the field of pharmacotherapy, particularly oral drugs, will be
dominant in the future management of sexual dysfunction. Basic research has led to the …

The range of therapies for treating erectile dys-function has expanded rapidly in recent
years, with a trend toward understanding the scientific basis of erectile function and …